Corcept Therapeutics | CORT - Trade Debtors


Corcept Therapeutics reported $76.92M in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 166.33M 17.95M Jun/2026
Alaunos Therapeutics USD 2K 0 Jun/2025
ANI Pharmaceuticals USD 274.47M 19.04M Jun/2026
Ardelyx USD 82.84M 10.99M Mar/2026
Aurora Cannabis CAD 44.58M 3.68M Mar/2026
BioMarin Pharmaceutical USD 1.06B 157.13M Jun/2026
Bristol-Myers Squibb USD 13.83B 535M Jun/2026
Canopy Growth CAD 36.29M 104.13M Mar/2026
Corcept Therapeutics USD 76.92M 37.85M Jun/2026
Eli Lilly USD 23.48B 2.3B Jun/2026
J&J USD 22.54B 1.21B Mar/2026
Knight Therapeutics CAD 183M 7.46M Dec/2025
Lexicon Pharmaceuticals USD 2.38M 50K Dec/2025
Merck USD 12.21B 435M Mar/2026
Nektar Therapeutics USD 3.6M 1.82M Mar/2026
Novartis USD 9.85B 252M Jun/2026
Novartis USD 9.6B 2.69B Mar/2026
Omeros USD 8.08M 440K Jun/2024
Pacira USD 132.42M 6.78M Jun/2026
Pfizer USD 16.19B 19M Jun/2026
Supernus Pharmaceuticals USD 211.66M 29.47M Jun/2026
TG Therapeutics USD 392.05M 86.42M Mar/2026